CCL2 and breast cancer: The inflammasome/IL-1 pathway is an important mechanism in the development of BC lung metastasis, as confirmed by the significant reduction of lung metastasis in inflammasome or caspase-1-deficient mice, and may be related to IL-1β-induced expression of CCL2 in macrophages and tumor cells [84].